Name:	pfe_CollaborativeArrangementCommittedInvestmentFromCollaboratorAmount
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

Collaborative Arrangement, Milestone Payment Upon Approval

No definition available.

Name:	pfe_CollaborativeArrangementMilestonePaymentUponApproval
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Collaborative Arrangement, Milestone Payment Upon Commercializing

No definition available.

Name:	pfe_CollaborativeArrangementMilestonePaymentUponCommercializing
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Investment, Ownership Percentage

No definition available.

Name:	pfe_InvestmentOwnershipPercentage
Namespace Prefix:	pfe_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	duration

Payments to Collaborators, Upfront Payment

No definition available.

Name:	pfe_PaymentsToCollaboratorsUpfrontPayment
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Prepayments and Payments to Collaborators, Cash

No definition available.

Name:	pfe_PrepaymentsAndPaymentsToCollaboratorsCash
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Prepayments and Payments to Collaborators

No definition available.

Name:	pfe_PrepaymentsandPaymentstoCollaborators
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Research And Development Arrangement, Collaborator's Development Cost Ownership Percentage

No definition available.

Name:	pfe_ResearchAndDevelopmentArrangementCollaboratorsDevelopmentCostOwnershipPercentage
Namespace Prefix:	pfe_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	duration

Research And Development Arrangement, Contingent Payments, Maximum Exposure1

No definition available.

Name:	pfe_ResearchAndDevelopmentArrangementContingentPaymentsMaximumExposure1
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Research And Development Arrangement, Future Milestone Payments, Maximum Exposure

No definition available.

Name:	pfe_ResearchAndDevelopmentArrangementFutureMilestonePaymentsMaximumExposure
Namespace Prefix:	pfe_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Research and Development Arrangement, Percentage of Costs to be Reimbursed

No definition available.

Name:	pfe_ResearchandDevelopmentArrangementPercentageofCoststobeReimbursed
Namespace Prefix:	pfe_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	duration

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

No definition available.

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479581/805-30-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-13

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Cash received from collaborators during the current period.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-25

Name:	us-gaap_ProceedsFromCollaborators
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482916/730-10-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482665/350-30-50-1

Name:	us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Name:	us-gaap_BusinessAcquisitionAxis=pfe_BiohavenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pfe_BioNTechMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pfe_ArvinasIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_CounterpartyNameAxis=pfe_BiohavenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_CounterpartyNameAxis=pfe_BioNTechMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=pfe_ShinglesVaccineProgramMRNABasedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_IncomeStatementLocationAxis=pfe_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=pfe_CoronavirusVaccineProgramMRNABasedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_CounterpartyNameAxis=pfe_BeamMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	dei_LegalEntityAxis=pfe_BeamMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: